Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMT

Bone Marrow Transplantation
Per LjungmanD Veil

Abstract

The best treatment of CMV gastrointestinal disease has been controversial, with some centers adding intravenous (i.v.) Ig to antiviral chemotherapy. The aim of this retrospective survey was to compare the outcome of antiviral chemotherapy with or without i.v. Ig. A questionnaire was sent to centers belonging to the EBMT. Thirty-three patients with CMV gastrointestinal disease were reported, 22 patients were given antiviral chemotherapy alone and 11 patients a combination of antiviral chemotherapy and i.v. Ig. Eighteen of 33 (55%) patients responded to therapy, 13 of those treated with antiviral chemotherapy alone and five (45%) of those treated with the combination (P = NS). Patients with acute GVHD of grades II-IV had significantly worse outcomes than patients with acute GVHD grades 0-I. In a Cox proportional hazards model corrected for acute GVHD there was no difference in outcome of CMV gastrointestinal disease with or without addition of Ig. Survival at 100 days after diagnosis of CMV gastrointestinal disease was 64%. There was no difference in survival in patients treated with or without i.v. Ig. The results of this retrospective survey indicate that addition of i.v. Ig to antiviral chemotherapy might not improve outcome i...Continue Reading

Citations

Apr 24, 2010·International Journal of Hematology·Takehiko Mori, Jun Kato
Feb 19, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W G Nichols, M Boeckh
Jul 1, 2008·Bone Marrow Transplantation·P LjungmanUNKNOWN European Conference on Infections in Leukemia
Jul 9, 2002·British Journal of Haematology·Per Ljungman
Feb 13, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J G T VehreschildUNKNOWN German Society of Hematology and Oncology
Sep 18, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Toru AraiSeiji Hayashi
Mar 21, 2009·Blood·Michael Boeckh, Per Ljungman
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M Boeckh
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L Rasmussen
Jan 1, 2009·Current Hematologic Malignancy Reports·Ahrin Koppel, Gary Schiller
Aug 19, 2008·Current Oncology Reports·Ahrin Koppel, Gary Schiller
Jan 18, 2011·Hematology/oncology Clinics of North America·Per LjungmanMichael Boeckh
May 15, 2010·Infectious Disease Clinics of North America·Per LjungmanMichael Boeckh
Oct 3, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dafna YahavMical Paul
May 8, 2013·British Journal of Haematology·Vincent EmeryUNKNOWN UK Virology Network
Apr 2, 2002·Best Practice & Research. Clinical Haematology·P Moss
Sep 27, 2005·Transplantation Proceedings·C De BartolomeisM Carmellini
Sep 7, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Harrys A TorresRoy F Chemaly
Mar 7, 2001·Gastrointestinal Endoscopy·J KeatesT Kowalski
Jun 24, 2003·The Journal of Laboratory and Clinical Medicine·Pavan Reddy, James L M Ferrara
Sep 29, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Yaping SunPavan Reddy
Oct 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Lia MinculescuHenrik Sengeloev
Aug 30, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sandra MiklosGerhard C Hildebrandt
Nov 1, 2016·Expert Review of Hematology·Franco LocatelliPietro Merli
Oct 19, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Juan Gea-BanaclocheJohn R Wingard
May 15, 2001·Journal of the American College of Nutrition·G D MillerL D McBean
Jun 12, 2013·Journal of Intensive Care Medicine·Giovanna Travi, Steven A Pergam
Apr 13, 2004·Bone Marrow Transplantation·P LjungmanUNKNOWN European Group for Blood and Marrow Transplantation
Jan 10, 2001·Bone Marrow Transplantation·N TanakaT Morishima
Apr 21, 2004·International Journal of Technology Assessment in Health Care·Mary E JohnstonGeorge P Browman
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Eric ManheimerLex M Bouter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.